“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained.
Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.
The outflow view (A), inflow view (B) and side view (C) of the Vienna Aortic Self-Expandable Transcatheter Valve. Image courtesy of the American Journal of Cardiology and Briedis et al.
The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary.
Researchers have recently determined that the medication, originally developed to treat diabetes, can contribute to weight loss and reduce a patient's MACE risk by up to 20%.
A majority of the proceeds raised would go toward "general corporate purposes," which could mean anything from research and development to investments in other healthcare companies.